Human GIPR, recombinant (VLP)

Human GIPR, recombinant (VLP)
Item number Size Datasheet Manual SDS Delivery time Quantity Price
NOV-C41R.20ug 20 µg - -

10 - 15 business days*

780.00€
NOV-C41R.100ug 100 µg - -

10 - 15 business days*

1,560.00€
NOV-C41R.500ug 500 µg - -

10 - 15 business days*

4,995.00€
 
Recombinant Human Gastric inhibitory polypeptide receptor is produced by our Mammalian expression... more
Product information "Human GIPR, recombinant (VLP)"
Recombinant Human Gastric inhibitory polypeptide receptor is produced by our Mammalian expression system and the target gene encoding Arg22-Arg421(Thr345Phe) is expressed with a Flag tag at C-terminus. A mutation (Thr345Phe) is introduced to stabilize the Human GIPR protein. VLPs are self-assembled from viral envelope/capsid protein and can display conformationally intact membrane protein in natural cell membranes. Protein function: This is a receptor for GIP. The activity of this receptor is mediated by G proteins which activate adenylyl cyclase. [The UniProt Consortium]
Keywords: GIPR, GIP-R, Gastric inhibitory polypeptide receptor, Glucose-dependent insulinotropic polypeptide receptor, Recombinant Human GIPR (VLP)
Supplier: Novoprotein
Supplier-Nr: C41R

Properties

Conjugate: No
Host: Human cells
Species reactivity: human
MW: 50.4 kD
Format: Solution

Database Information

KEGG ID : K04580 | Matching products
UniProt ID : P48546 | Matching products

Handling & Safety

Storage: -80°C (avoid repeat freezing and thawing cycles)
Shipping: -20°C (International: -20°C)
Caution
Our products are for laboratory research use only: Not for administration to humans!
Information about the product reference will follow. more
You will get a certificate here
or to request a certificate of analysis.
Read, write and discuss reviews... more
Customer review for "Human GIPR, recombinant (VLP)"
Write a review
or to review a product.
Viewed